FDA clearance will allow commercialisation in the US
In addition, the key partnerships HMD has with the world renowned Mayo Clinic and biotech leader Teva pharmaceuticals, these partners can now evaluate commercialisation efforts with HMD
Huge build up already and a very tight capital structure with not many free floating shares available and a low market cap is conducive to a significant run being setup IMO
Ann: HeraMED Receives FDA 510(k) Clearance for HeraBEAT Device, page-7
Add HMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.181M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| HMD (ASX) Chart |
Day chart unavailable